Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • News

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    2117
    PDF: 1688
    HTML: 375
  • ACUTE PROMYELOCYTIC LEUKEMIA: AN EXPERIENCE ON 95 GREEK PATIENTS TREATED IN THE ALL-TRANS-RETINOIC ACID ERA

    Maria Pagoni, Maria Garofalaki, Fotios Panitsas, Kalliopi Manola, Katerina Psarra, Panagiotis Economopoulos
    e2011053
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.053
    2824
    PDF: 872
    HTML: 3472
  • “IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”

    Sara Martinelli, Antonio Cuneo, Gian Matteo Rigolin
    e2016047
    2016-10-15
    https://doi.org/10.4084/mjhid.2016.047
    3990
    PDF: 1049
    HTML: 3589
    Untitled: 177
    Cneo. Fig.1: 113
    Untitled: 104
    Untitled: 126
    Untitled: 131
  • THE GROWING ROLE OF THE BH3 MIMETIC DRUG VENETOCLAX IN THE THERAPY OF ACUTE MYELOID LEUKEMIA

    Elvira Pelosi, Dr. Germana Castelli, Ugo Testa
    e2022080
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.080
    1474
    PDF: 1143
    HTML: 272
  • CURRENT STRATEGIES FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

    Juliana Maria Camargos Rocha, Sandra Guerra Xavier, Marcelo Eduardo Lima Souza, Juliana Godoy Assumpção, Mitiko Murao, Benigna Maria Oliveira
    e2016024
    2016-04-10
    https://doi.org/10.4084/mjhid.2016.024
    4572
    PDF: 1335
    HTML: 4622
  • PLASMA CELL LEUKEMIA UPDATE ON IMMUNOPHENOTYPE, MOLECULAR CHARACTERISTICS, AND THERAPY. The second part of plasma cell neoplasms with spreading in the blood and tissues Plasma Cell Leukemia

    Giuseppe G.M. Leone, Ugo Testa
    e2025080
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.080
    1034
    PDF: 348
    Html: 102
  • TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA

    Michele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, Francesca Palandri, Gianantonio Rosti
    e2014005
    2014-01-02
    https://doi.org/10.4084/mjhid.2014.005
    3309
    PDF: 1465
    HTML: 3998
  • NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL

    Dimitar Efremov, Adrian Wiestner, Luca Laurenti
    e2012067
    2012-10-09
    https://doi.org/10.4084/mjhid.2012.067
    2486
    PDF: 837
    HTML: 8819
    Efremov 1: 226
    Efremov 2: 187
  • TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS

    Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Chiara Sarlo, Luigi Di Caprio, Concetta Ditto, Federica Giannotti, Daniela Nasso, Eleonora Ceresoli, Massimiliano Postorino, Marco Refrigeri, Sergio Amadori, Adriano Venditti
    e2013032
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.032
    2797
    PDF: 1005
    HTML: 5519
  • IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

    Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos
    e2012052
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.052
    3051
    PDF: 873
    HTML: 7162
    Kost Fig1: 182
    Kost Fig 2: 177
    Kost Fig3: 174
    Kost Fig 4: 189
    Kost Fig5: 184
    Kost fig 6: 173
  • NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms

    Gianfranco Catalano, Pasquale Niscola, Cristina Banella, Daniela Diverio, Malgorzata Monika Trawinska , Stefano Fratoni, Rita Iazzoni, Paolo de Fabritiis, Elisabetta abruzzese, Nelida Ines Noguera
    e2020083
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.083
    1652
    PDF: 1173
    HTML: 200
  • CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2022069
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.069
    2942
    PDF: 889
    HTML: 1870
  • BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL

    Ugo Testa, Elvira Pelosi, Germana Castelli, Patrizia Chiusolo
    e2024070
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.070
    1620
    PDF: 1092
    HTML: 116
  • PROGNOSTIC SIGNIFICANCE OF TRANSCRIPT-TYPE BCR/ABL1 IN CHRONIC MYELOID LEUKEMIA

    matteo molica, elisabetta abruzzese, massimo breccia
    e2020062
    2020-09-12
    https://doi.org/10.4084/mjhid.2020.062
    3614
    PDF: 1576
    HTML: 617
  • THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

    Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra
    e2011031
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.031
    2248
    PDF: 934
    HTML: 2366
  • GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

    Francesco Fabozzi, Angela Mastronuzzi
    e2023032
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.032
    1921
    PDF: 503
    HTML: 536
  • SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML

    Francesco D'Alò, Luana Fianchi, Emiliano Fabiani, Marianna Criscuolo, Mariangela Greco, Francesco Guidi, Livio Pagano, Giuseppe Leone, Maria Teresa Voso
    e2011052
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.052
    3578
    PDF: 881
    HTML: 6710
  • ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti, Michela Tarnani, Patrizia Chiusolo, Federica Sorà, Simona Sica
    e2010026
    2010-08-31
    https://doi.org/10.4084/mjhid.2010.026
    1362
    PDF: 754
    HTML: 942
  • DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

    Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
    e2022030
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.030
    1370
    HTML: 391
    PDF: 818
  • BRUTON’S TYROSINE KINASE (BTK) MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A CLINICAL VIEW.

    Stefano Molica
    e2025053
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.053
    1557
    PDF: 894
    HTML: 116
  • THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition

    Emiliano Fabiani, Dr. Falconi, Dr. Cristiano, Dr. Hajrullaj, Dr. Falconi, Prof. Leone, Prof. Voso
    e2023064
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.064
    1331
    PDF: 822
    HTML: 129
  • PROGNOSTIC IMPACT OF NEUROPILIN-1 EXPRESSION IN EGYPTIAN CHILDREN WITH B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA

    adel abd elhaleim hagag, Nahla A Nosair
    e2015009
    2014-12-28
    https://doi.org/10.4084/mjhid.2015.009
    1633
    PDF: 816
    HTML: 2108
  • RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES

    Julie Schanz, Friederike Braulke, Detlef Haase
    e2015034
    2015-04-23
    https://doi.org/10.4084/mjhid.2015.034
    3760
    PDF: 1652
    HTML: 11579
    Figures Haase: 198
  • ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?

    Maria L. Delioukina, Stephen J. Forman
    e2010018
    2010-06-30
    https://doi.org/10.4084/mjhid.2010.018
    1230
    PDF: 786
    HTML: 539
  • THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

    Elihu Estey
    e2013050
    2013-07-12
    https://doi.org/10.4084/mjhid.2013.050
    2133
    PDF: 732
    HTML: 1629
  • CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY

    Daichi Inoue, Hayato Maruoka, Takayuki Takahashi
    e2010020
    2010-08-05
    https://doi.org/10.4084/mjhid.2010.020
    1259
    PDF: 753
    HTML: 1164
  • ASSOCIATION BETWEEN LEUKEMIC EVOLUTION AND UNCOMMON CHROMOSOMAL ALTERATIONS IN PEDIATRIC MYELODYSPLASTIC SYNDROME

    Viviane Lamim Lovatel, Beatriz Ferreira da Silva , Eliane Ferreira Rodrigues , Maria Luiza Rocha da Rosa Borges , Rita de Cássia Barbosa Tavares, Ana Paula Silva Bueno, Elaine Sobral da Costa, Terezinha de Jesus Marques , Teresa de Souza Fernandez
    e2024003
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.003
    1166
    PDF: 1370
    HTML: 132
  • T-cell Large Granular Lymphocytic Leukemia Manifesting in Patients with HIV-1 Infection: Cases Series and Review of the Literature

    Ashley M Rose, Leidy Isenalumhe, Magali VanDenBergh, Lubomir Sokol
    e2018036
    2018-06-21
    https://doi.org/10.4084/mjhid.2018.036
    2533
    PDF: 910
    HTML: 314
  • BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

    Maria Teresa Voso, Giulia Falconi, Dr. Fabiani
    e2023055
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.055
    1778
    PDF: 965
    HTML: 141
  • THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA

    Yingying Li, Yang Li, Wenguo Cheng
    e2025073
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.073
    473
    PDF: 243
    HTML: 77
  • Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide

    Enrico Santinelli, Maria Rosaria Pascale, Luca Guarnera, Arianna Savi, Flavia Mallegni, Carmelo Gurnari, Luca Maurillo, Maria Teresa Voso, Susanna Fenu
    e2025038
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.038
    1006
    PDF: 721
    HTML: 83
  • Morphologic confounders and CD19 negativity in a case of hairy cell leukemia.

    Pulkit Rastogi, Sreejesh Sreedharanunni, Uday Yanamandra, Man Updesh Singh Sachdeva, Neelam Varma
    e2017033
    2017-05-01
    https://doi.org/10.4084/mjhid.2017.033
    2255
    PDF: 863
    HTML: 1215
  • A POPULATION-BASED STUDY ON MYELODYSPLASTIC SYNDROMES IN THE LAZIO REGION (ITALY), MEDICAL MISCODING AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

    Flavia Mayer, Laura Faglioni, Nera Agabiti, Susanna Fenu, Francesco Buccisano, Roberto Latagliata, Roberto Ricci, Maria Antonietta Aloe Spiriti, Caterina Tatarelli, Massimo Breccia, Giuseppe Cimino, Luana Fianchi, Svitlana Gumenyuk, Stefano Mancini, Luca Maurillo, Carolina Nobile, Pasquale Niscola, Anna Lina Piccioni, Agostino Tafuri, Giulio Trapè, Alessandro Andriani, Paolo De Fabritis, Maria Teresa Voso, Marina Davoli, Gina Zini
    e2017046
    2017-07-01
    https://doi.org/10.4084/mjhid.2017.046
    2644
    PDF: 996
    HTML: 1108
  • MICRORNA-181A-3P AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER FOR ACUTE MYELOID LEUKEMIA

    Xiaoling Ma
    e2020012
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.012
    1669
    PDF: 1028
    HTML: 202
  • Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission

    Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Antonio Cristiano, TIZIANA OTTONE, Maria Cristina Rapanotti, Mariadomenica Divona, SERENA TRAVAGLINI, Enrico Attardi, Elisa Buzzatti, Francesco Buccisano, Maria Teresa Voso
    e2022058
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.058
    1657
    PDF: 746
    HTML: 243
  • The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones

    Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, Tiziana Ottone, Mariadomenica Divona, Arianna Savi, Francesco Buccisano, Luca Maurillo, Corrado Tarella, William Arcese, Maria Teresa Voso
    e2022041
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.041
    1227
    PDF: 756
    HTML: 313
  • GOOD OUTCOME FOR VERY HIGH RISK ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA CARRYING GENETIC ABNORMALITIES t(4;11)(q21;q23) or t(9;22)(q34;q11), IF PROMPTLY SUBMITTED TO ALLOGENEIC TRANSPLANTATION, AFTER OBTAINING A GOOD MOLECULAR REMISSION.

    Matteo Parma, Clara Vigano', Monica Fumagalli, Federica Colnaghi, Arianna Colombo, Federica Mottadelli, Vincenzo Rossi, Elena Elli, Elisabetta Terruzzi, Angelo Belotti, Giovanni Cazzaniga, Enrico Maria Pogliani, Pietro Pioltelli
    e2015041
    2015-05-26
    https://doi.org/10.4084/mjhid.2015.041
    2191
    PDF: 1020
    HTML: 1186
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    1983
    PDF: 1123
    HTML: 620
  • RECENT ADVANCES IN THE 5Q- SYNDROME

    Andrea Pellagatti, Jacqueline Boultwood
    e2015037
    2015-05-20
    https://doi.org/10.4084/mjhid.2015.037
    2767
    PDF: 1807
    HTML: 3665
    Pellagatti Fig 1: 214
    Pellagatti Fig. 2: 209
  • HHVs AND LYMPHOPROLIFERATIVE DISORDERS

    C Quadrelli, P Barozzi, G Riva, Mario Luppi
    e2011043
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.043
    1381
    PDF: 816
    HTML: 3121
  • Morphologic leukemia-free state after venetoclax-based therapy in acute myeloid leukemia is associated with high relapse despite preserved short-term survival

    Kenta Motegi
    e2026048
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.048
    197
    PDF: 211
    HTML: 16
  • 5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature

    Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Livio Pagano, Maria Teresa Voso
    e2011011
    2011-03-14
    https://doi.org/10.4084/mjhid.2011.011
    1581
    PDF: 759
    HTML: 1111
  • AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.

    Pasquale Niscola
    e2014020
    2014-02-16
    https://doi.org/10.4084/mjhid.2014.020
    1647
    PDF: 889
    HTML: 2784
  • Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome presenting t(11;16) (q23; q24)

    Viviane Lamim Lovatel, Luize Otero, Ercole Pietro Orlando, Claudia Diniz, Filipe Vicente dos Santos-Bueno, Bruno Almeida Lopes, Elaiza Almeida Antônio de Kós, Monica Kopischitz Praxedes Lusis, Eliana Abdelhay, Teresa de Souza Fernandez
    e2022013
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.013
    1097
    PDF: 549
    HTML: 219
  • THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies

    Emine Atli, Rasime Kalkan, Cisem Mail, Damla Eker, Ufuk Demirci, Selma Demir, Sinem Yalcintepe, Hakki Onur Kirkizlar, Engin Atli, Hakan Gurkan, Ahmet Muzaffer Demir
    e2021013
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.013
    1518
    PDF: 533
    HTML: 269
  • Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy

    Pasquale Niscola
    e2013030
    2013-04-16
    https://doi.org/10.4084/mjhid.2013.030
    1179
    PDF: 751
    HTML: 1347
    Figure 1: 186
    Figure 2: 188
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND CLINICAL PROBLEMS

    Michele Bibas, Shayna Sarosiek, Jorge J. Castillo
    e2024061
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.061
    2742
    PDF: 3200
    HTML: 375
  • IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA

    Ugo Testa, Prof. Leone, Dr. Elvira Pelosi, Dr. Germana Castelli, Prof, Valerio De Stefano
    e2024044
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.044
    2544
    PDF: 1130
    HTML: 139
  • FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells

    Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo
    e2024029
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.029
    946
    PDF: 1204
    HTML: 108
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
    e2021062
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.062
    1217
    PDF: 464
    HTML: 155
1 - 50 of 126 items 1 2 3 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy